$APCX
AppTech Payments Corp.

2023 Q3 Form 10-Q Financial Statement

#000168316823005753 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $140.0K $134.0K $123.0K
YoY Change 21.74% 8.94% -18.54%
Cost Of Revenue $44.00K $62.00K $62.00K
YoY Change -18.52% 0.0% 72.22%
Gross Profit $96.00K $72.00K $61.00K
YoY Change 57.38% 18.03% -46.96%
Gross Profit Margin 68.57% 53.73% 49.59%
Selling, General & Admin $2.230M $2.816M $1.320M
YoY Change 63.37% 113.33% -75.43%
% of Gross Profit 2322.92% 3911.11% 2163.93%
Research & Development $751.0K $498.0K $2.884M
YoY Change -50.36% -82.73%
% of Gross Profit 782.29% 691.67% 4727.87%
Depreciation & Amortization $120.0K $293.0K
YoY Change
% of Gross Profit 125.0% 406.94%
Operating Expenses $2.978M $9.445M $4.276M
YoY Change 3.47% 120.88% -8.08%
Operating Profit -$2.882M -$9.373M -$4.215M
YoY Change 2.31% 122.37% -7.1%
Interest Expense $0.00 $3.000K $41.00K
YoY Change -100.0% -92.68% -98.31%
% of Operating Profit
Other Income/Expense, Net -$9.000K $290.0K $88.00K
YoY Change -71.88% 229.55% -104.88%
Pretax Income -$2.891M -$9.083M -$4.127M
YoY Change 1.47% 120.09% -34.92%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.891M -$9.083M -$4.127M
YoY Change 1.47% 120.09% -34.91%
Net Earnings / Revenue -2065.0% -6778.36% -3355.28%
Basic Earnings Per Share -$0.15 -$0.49 -$0.25
Diluted Earnings Per Share -$0.15 -$0.49 -$254.0K
COMMON SHARES
Basic Shares Outstanding 18.52M shares 18.54M shares 16.25M shares
Diluted Shares Outstanding 18.80M shares 18.47M shares 16.25M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.0K $749.0K $7.790M
YoY Change -95.75% -90.39% 2099.45%
Cash & Equivalents $251.0K $749.0K $7.790M
Short-Term Investments
Other Short-Term Assets $320.0K $333.0K $945.0K
YoY Change -68.9% -64.76% 2477.04%
Inventory
Prepaid Expenses $324.0K $333.0K $466.0K
Receivables $253.0K $442.0K $50.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $828.0K $1.524M $8.785M
YoY Change -88.18% -82.65% 1794.63%
LONG-TERM ASSETS
Property, Plant & Equipment $80.00K $97.00K $158.0K
YoY Change -44.06% -38.61% -27.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $9.000K $3.188M
YoY Change -99.67% -99.72% 9697.17%
Total Long-Term Assets $1.615M $1.706M $7.404M
YoY Change -81.59% -76.96% 4.28%
TOTAL ASSETS
Total Short-Term Assets $828.0K $1.524M $8.785M
Total Long-Term Assets $1.615M $1.706M $7.404M
Total Assets $2.443M $3.230M $16.19M
YoY Change -84.52% -80.05% 114.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $552.0K $478.0K $394.0K
YoY Change 44.13% 21.32% -68.97%
Accrued Expenses $340.0K $578.0K $1.651M
YoY Change -80.31% -64.99% -17.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.000K $1.784M
YoY Change -100.0% -99.94% -26.98%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.528M $1.525M $4.749M
YoY Change -68.33% -67.89% -29.94%
LONG-TERM LIABILITIES
Long-Term Debt $70.00K $67.00K $67.00K
YoY Change 4.48% 0.0% 4.2%
Other Long-Term Liabilities $30.00K $51.00K $131.0K
YoY Change -73.91% -61.07% -43.0%
Total Long-Term Liabilities $99.00K $118.0K $198.0K
YoY Change -45.6% -40.4% -32.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.528M $1.525M $4.749M
Total Long-Term Liabilities $99.00K $118.0K $198.0K
Total Liabilities $1.627M $1.643M $4.947M
YoY Change -67.5% -66.79% -30.06%
SHAREHOLDERS EQUITY
Retained Earnings -$156.4M -$153.5M -$133.8M
YoY Change 15.21% 14.72%
Common Stock $19.00K $19.00K $16.00K
YoY Change 18.75% 18.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $816.0K $1.587M $11.24M
YoY Change
Total Liabilities & Shareholders Equity $2.443M $3.230M $16.19M
YoY Change -84.52% -80.05% 114.03%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$2.891M -$9.083M -$4.127M
YoY Change 1.47% 120.09% -34.91%
Depreciation, Depletion And Amortization $120.0K $293.0K
YoY Change
Cash From Operating Activities -$1.130M -$2.366M -$2.500M
YoY Change 206.23% -5.36% 635.92%
INVESTING ACTIVITIES
Capital Expenditures $50.00K $0.00 $0.00
YoY Change -103.2% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K $0.00 $0.00
YoY Change -96.8% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 680.0K -279.0K 0.000
YoY Change 3300.0% -100.0%
NET CHANGE
Cash From Operating Activities -1.130M -2.366M -2.500M
Cash From Investing Activities -50.00K 0.000 0.000
Cash From Financing Activities 680.0K -279.0K 0.000
Net Change In Cash -500.0K -2.645M -2.500M
YoY Change -73.85% 5.8% 848.37%
FREE CASH FLOW
Cash From Operating Activities -$1.130M -$2.366M -$2.500M
Capital Expenditures $50.00K $0.00 $0.00
Free Cash Flow -$1.180M -$2.366M -$2.500M
YoY Change -198.83% -5.36% -6305.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001070050
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-27569
dei Entity Registrant Name
EntityRegistrantName
AppTech Payments Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0847995
dei Entity Address Address Line1
EntityAddressAddressLine1
5876 Owens Ave. Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
dei City Area Code
CityAreaCode
(760)
dei Local Phone Number
LocalPhoneNumber
707-5959
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18523675 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
749000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3462000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
442000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
333000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183000 usd
CY2023Q2 apcx Prepaid License Fees Current
PrepaidLicenseFeesCurrent
0 usd
CY2022Q4 apcx Prepaid License Fees Current
PrepaidLicenseFeesCurrent
729000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1524000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4425000 usd
CY2022Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2700000 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
243000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
311000 usd
CY2023Q2 apcx Note Receivable Current
NoteReceivableCurrent
26000 usd
CY2022Q4 apcx Note Receivable Current
NoteReceivableCurrent
26000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127000 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9000 usd
CY2023Q2 apcx Capitalized Software Development And License Net Of Accumulated Amortization
CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization
1331000 usd
CY2022Q4 apcx Capitalized Software Development And License Net Of Accumulated Amortization
CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization
4921000 usd
CY2023Q2 us-gaap Assets
Assets
3230000 usd
CY2022Q4 us-gaap Assets
Assets
12519000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
478000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
347000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
578000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1870000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
78000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64000 usd
CY2023Q2 apcx Stock Repurchase Liability
StockRepurchaseLiability
0 usd
CY2022Q4 apcx Stock Repurchase Liability
StockRepurchaseLiability
430000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4000 usd
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
676000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1021000 usd
CY2023Q2 apcx Notes Payable Related Parties
NotesPayableRelatedParties
0 usd
CY2022Q4 apcx Notes Payable Related Parties
NotesPayableRelatedParties
88000 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
390000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
0 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1525000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4929000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
67000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
118000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
166000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1643000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5095000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18581447 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18581447 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16697280 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16697280 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155039000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147881000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153471000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140474000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1587000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3230000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12519000 usd
CY2023Q2 us-gaap Revenues
Revenues
134000 usd
CY2022Q2 us-gaap Revenues
Revenues
123000 usd
us-gaap Revenues
Revenues
223000 usd
us-gaap Revenues
Revenues
227000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
62000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
62000 usd
us-gaap Cost Of Revenue
CostOfRevenue
115000 usd
us-gaap Cost Of Revenue
CostOfRevenue
113000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
72000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
61000 usd
us-gaap Gross Profit
GrossProfit
108000 usd
us-gaap Gross Profit
GrossProfit
114000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2816000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1320000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4887000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4101000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
498000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2884000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2023000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4936000 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
6131000 usd
CY2022Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
6131000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q2 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
0 usd
CY2022Q2 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
72000 usd
apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
0 usd
apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
904000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9445000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4276000 usd
us-gaap Operating Expenses
OperatingExpenses
13041000 usd
us-gaap Operating Expenses
OperatingExpenses
9941000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9373000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4215000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12933000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9827000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-41000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-43000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-96000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
37000 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
27000 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
173000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
287000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
92000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
715000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
168000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
290000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
88000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
699000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
245000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9083000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4127000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12234000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9582000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9083000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4127000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9582000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9083000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4127000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9582000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
763000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9083000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4127000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12997000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9582000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18468741 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18468741 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16246260 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16246260 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18200197 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18200197 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15857753 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15857753 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5455000 usd
CY2022Q1 apcx Common Stock Issued For Forbearance Amount
CommonStockIssuedForForbearanceAmount
3000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2732000 usd
CY2022Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-0 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13395000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10719000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4127000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2120000 usd
CY2022Q2 apcx Patent Acquisition Value
PatentAcquisitionValue
407000 usd
CY2022Q2 apcx Antidilution Provision Shares
AntidilutionProvisionShares
451957 shares
CY2022Q2 apcx Antidilution Provision Value
AntidilutionProvisionValue
2123000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11242000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3151000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
860000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
234000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4490000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9857000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9083000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
813000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1587000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9582000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1673000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4603000 usd
apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
-0 usd
apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
-3000 usd
apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
430000 usd
apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
-0 usd
apcx Stock Issued For Excess Fair Value Of Equity Over Assets Received
StockIssuedForExcessFairValueOfEquityOverAssetsReceived
0 usd
apcx Stock Issued For Excess Fair Value Of Equity Over Assets Received
StockIssuedForExcessFairValueOfEquityOverAssetsReceived
904000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
32000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
586000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
6131000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
apcx Gain On Settlement Of Derivative Liabilities
GainOnSettlementOfDerivativeLiabilities
250000 usd
apcx Gain On Settlement Of Derivative Liabilities
GainOnSettlementOfDerivativeLiabilities
-0 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-27000 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-173000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
391000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-454000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
29000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
129000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-861000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1447000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-266000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
390000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
apcx Increase Decrease Right Of Use Asset And Liability
IncreaseDecreaseRightOfUseAssetAndLiability
-4000 usd
apcx Increase Decrease Right Of Use Asset And Liability
IncreaseDecreaseRightOfUseAssetAndLiability
1000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5416000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5378000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
185000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
88000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1020000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
679000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
4490000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
13395000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2703000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13345000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2713000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7782000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3462000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
749000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7790000 usd
us-gaap Interest Paid Net
InterestPaidNet
1429000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
apcx Issuance Stock For Acquisition Of Intangible Assets
IssuanceStockForAcquisitionOfIntangibleAssets
0 usd
apcx Issuance Stock For Acquisition Of Intangible Assets
IssuanceStockForAcquisitionOfIntangibleAssets
407000 usd
apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
430000 usd
apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
234000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
250000 usd
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
9.5 to 1
CY2021Q4 apcx Sale Of Stock Units
SaleOfStockUnits
4.15
CY2023Q3 apcx Remaining Amount For Shelf Registration
RemainingAmountForShelfRegistration
70000000 usd
CY2023Q2 apcx Accrued Liabilities
AccruedLiabilities
578000 usd
CY2022Q4 apcx Accrued Liabilities
AccruedLiabilities
1870000 usd
CY2022Q4 apcx Notes Payable Related Parties
NotesPayableRelatedParties
88000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zi5SCMlKAg7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86D_zEYtpa6v3jd1">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated liabilities related to various vendors in which communications have ceased, contingent liabilities, valuation of the derivative liabilities, and realization of tax deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zNU3Q4gOATvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zYR6p3YRRP1l">Concentration of Credit Risk</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounts receivable from merchant services are paid by the financial institutions on a monthly basis. The Company currently uses six financial institutions to service their merchants for which represented 100% of accounts receivable as of June 30, 2023 and 2022. The loss of one of these financial institutions would not have a significant impact on the Company’s operations as there are additional financial institutions available to the Company. There is no merchant (customer) representing a significant amount of total revenue for the three and six months ended June 30, 2023 and for the year ended 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7357993 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6176102 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7357993 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6176102 shares
apcx Derivative Loss On Derivative1
DerivativeLossOnDerivative1
390000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27000 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
166000 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
5200000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
800000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2023Q2 apcx Interest Payable
InterestPayable
0 usd
CY2022Q4 apcx Interest Payable
InterestPayable
1436000 usd
CY2023Q2 apcx Employee Related Liabilities
EmployeeRelatedLiabilities
429000 usd
CY2022Q4 apcx Employee Related Liabilities
EmployeeRelatedLiabilities
311000 usd
CY2023Q2 apcx Accrued Residuals
AccruedResiduals
36000 usd
CY2022Q4 apcx Accrued Residuals
AccruedResiduals
31000 usd
CY2023Q2 apcx Antidilution Provision Payable
AntidilutionProvisionPayable
72000 usd
CY2022Q4 apcx Antidilution Provision Payable
AntidilutionProvisionPayable
72000 usd
CY2023Q2 apcx Other Accrued Liabilities
OtherAccruedLiabilities
41000 usd
CY2022Q4 apcx Other Accrued Liabilities
OtherAccruedLiabilities
20000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27000 usd
apcx Extinguishment Of Derivative Liability
ExtinguishmentOfDerivativeLiability
406000 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
90000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
142000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
129000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
36000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
31000 usd
CY2023Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
880000 usd
apcx Gain On Settlement Of Litigation Related To Convertible Note And Warrants
GainOnSettlementOfLitigationRelatedToConvertibleNoteAndWarrants
250000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1089868000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M28D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
175658000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.96
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
914210000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M23D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
881012000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.93
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y8M19D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
44000 usd
apcx Share Based Compensation Modification Expense
ShareBasedCompensationModificationExpense
711 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5823036 shares

Files In Submission

Name View Source Status
0001683168-23-005753-index-headers.html Edgar Link pending
0001683168-23-005753-index.html Edgar Link pending
0001683168-23-005753.txt Edgar Link pending
0001683168-23-005753-xbrl.zip Edgar Link pending
apcx-20230630.xsd Edgar Link pending
apptech_ex3101.htm Edgar Link pending
apptech_ex3102.htm Edgar Link pending
apptech_ex3201.htm Edgar Link pending
apptech_ex3202.htm Edgar Link pending
apptech_i10q-063023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
apcx-20230630_cal.xml Edgar Link unprocessable
apcx-20230630_pre.xml Edgar Link unprocessable
apcx-20230630_def.xml Edgar Link unprocessable
apcx-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apptech_i10q-063023_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending